Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Supply, Demand and Key Producers, 2023-2029
The global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization), and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) total market, 2018-2029, (USD Million)
Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) total market, key domestic companies and share, (USD Million)
Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) revenue by player and market share 2018-2023, (USD Million)
Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) total market by Type, CAGR, 2018-2029, (USD Million)
Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Catalent, Patheon (Thermo Fisher Scientific), Aenova, Siegfried, Recipharm, Strides Shasun, Piramal and Metrics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market, By Region:
1. How big is the global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market?
2. What is the demand of the global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market?
3. What is the year over year growth of the global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market?
4. What is the total value of the global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market?
5. Who are the major players in the global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market?
6. What are the growth factors driving the market demand?
This report studies the global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization), and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) total market, 2018-2029, (USD Million)
Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) total market, key domestic companies and share, (USD Million)
Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) revenue by player and market share 2018-2023, (USD Million)
Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) total market by Type, CAGR, 2018-2029, (USD Million)
Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Catalent, Patheon (Thermo Fisher Scientific), Aenova, Siegfried, Recipharm, Strides Shasun, Piramal and Metrics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Intermediate CDMO
- API CDMO
- Formulation CDMO
- Protein CDMO
- Gene Therapy CDMO
- Cell Therapy CDMO
- Pharmaceutical Company
- Biotechnology Company
- Generic Company
- Others
- Lonza
- Catalent
- Patheon (Thermo Fisher Scientific)
- Aenova
- Siegfried
- Recipharm
- Strides Shasun
- Piramal
- Metrics
- AMRI
- Famar
- WuXi AppTech
- Asymchem
- Porton
- Amatsigroup
- AcuraBio
- Moravek
- Ascendia Pharmaceuticals
- Ardena
- CPL
- Arranta Bio
- UPM Pharmaceuticals
- FUJIFILM Diosynth Biotechnologies
- Groupe Parima
- TBD Pharmatech
- Avid Bioservices
- Vetter Pharma
- NextPharma
- Alcami
- NerPharMa
- Vetio
- Societal CDMO
- ten23 health
- Piramal Pharma Solutions
- MedPharm
- Lundbeck
- AGC Pharma Chemicals
- BioVectra
- Pfizer CentreOne
- Jubilant Biosys
- SEIKAGAKU CORPORATION
- Mikart
- Adare Pharma Solutions
- Fermion
- Samsung Biologics
- Siegfried Holdings
- Boehringer Ingelheim
- Jubilant Pharmova Limited
- Fareva SA
1. How big is the global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market?
2. What is the demand of the global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market?
3. What is the year over year growth of the global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market?
4. What is the total value of the global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market?
5. Who are the major players in the global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction
1.2 World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Total Market by Region (by Headquarter Location)
1.3.1 World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size (2018-2029)
1.3.3 China Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size (2018-2029)
1.3.4 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size (2018-2029)
1.3.5 Japan Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size (2018-2029)
1.3.6 South Korea Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size (2018-2029)
1.3.7 ASEAN Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size (2018-2029)
1.3.8 India Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value (2018-2029)
2.2 World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Region
2.2.1 World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Region (2018-2023)
2.2.2 World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value Forecast by Region (2024-2029)
2.3 United States Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value (2018-2029)
2.4 China Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value (2018-2029)
2.5 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value (2018-2029)
2.6 Japan Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value (2018-2029)
2.7 South Korea Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value (2018-2029)
2.8 ASEAN Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value (2018-2029)
2.9 India Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value (2018-2029)
3 WORLD PHARMACEUTICAL CDMO (PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION) COMPANIES COMPETITIVE ANALYSIS
3.1 World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) in 2022
3.2.3 Global Concentration Ratios (CR8) for Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) in 2022
3.3 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Company Evaluation Quadrant
3.4 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market: Overall Company Footprint Analysis
3.4.1 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market: Region Footprint
3.4.2 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market: Company Product Type Footprint
3.4.3 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value Comparison
4.2.1 United States VS China: Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Companies and Market Share, 2018-2023
4.3.1 United States Based Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, (2018-2023)
4.4 China Based Companies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue and Market Share, 2018-2023
4.4.1 China Based Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, (2018-2023)
4.5 Rest of World Based Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Intermediate CDMO
5.2.2 API CDMO
5.2.3 Formulation CDMO
5.2.4 Protein CDMO
5.2.5 Gene Therapy CDMO
5.2.6 Cell Therapy CDMO
5.3 Market Segment by Type
5.3.1 World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type (2018-2023)
5.3.2 World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type (2024-2029)
5.3.3 World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical Company
6.2.2 Biotechnology Company
6.2.3 Generic Company
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application (2018-2023)
6.3.2 World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application (2024-2029)
6.3.3 World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Lonza
7.1.1 Lonza Details
7.1.2 Lonza Major Business
7.1.3 Lonza Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.1.4 Lonza Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Lonza Recent Developments/Updates
7.1.6 Lonza Competitive Strengths & Weaknesses
7.2 Catalent
7.2.1 Catalent Details
7.2.2 Catalent Major Business
7.2.3 Catalent Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.2.4 Catalent Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Catalent Recent Developments/Updates
7.2.6 Catalent Competitive Strengths & Weaknesses
7.3 Patheon (Thermo Fisher Scientific)
7.3.1 Patheon (Thermo Fisher Scientific) Details
7.3.2 Patheon (Thermo Fisher Scientific) Major Business
7.3.3 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.3.4 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Patheon (Thermo Fisher Scientific) Recent Developments/Updates
7.3.6 Patheon (Thermo Fisher Scientific) Competitive Strengths & Weaknesses
7.4 Aenova
7.4.1 Aenova Details
7.4.2 Aenova Major Business
7.4.3 Aenova Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.4.4 Aenova Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Aenova Recent Developments/Updates
7.4.6 Aenova Competitive Strengths & Weaknesses
7.5 Siegfried
7.5.1 Siegfried Details
7.5.2 Siegfried Major Business
7.5.3 Siegfried Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.5.4 Siegfried Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Siegfried Recent Developments/Updates
7.5.6 Siegfried Competitive Strengths & Weaknesses
7.6 Recipharm
7.6.1 Recipharm Details
7.6.2 Recipharm Major Business
7.6.3 Recipharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.6.4 Recipharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Recipharm Recent Developments/Updates
7.6.6 Recipharm Competitive Strengths & Weaknesses
7.7 Strides Shasun
7.7.1 Strides Shasun Details
7.7.2 Strides Shasun Major Business
7.7.3 Strides Shasun Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.7.4 Strides Shasun Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Strides Shasun Recent Developments/Updates
7.7.6 Strides Shasun Competitive Strengths & Weaknesses
7.8 Piramal
7.8.1 Piramal Details
7.8.2 Piramal Major Business
7.8.3 Piramal Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.8.4 Piramal Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Piramal Recent Developments/Updates
7.8.6 Piramal Competitive Strengths & Weaknesses
7.9 Metrics
7.9.1 Metrics Details
7.9.2 Metrics Major Business
7.9.3 Metrics Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.9.4 Metrics Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Metrics Recent Developments/Updates
7.9.6 Metrics Competitive Strengths & Weaknesses
7.10 AMRI
7.10.1 AMRI Details
7.10.2 AMRI Major Business
7.10.3 AMRI Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.10.4 AMRI Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 AMRI Recent Developments/Updates
7.10.6 AMRI Competitive Strengths & Weaknesses
7.11 Famar
7.11.1 Famar Details
7.11.2 Famar Major Business
7.11.3 Famar Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.11.4 Famar Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Famar Recent Developments/Updates
7.11.6 Famar Competitive Strengths & Weaknesses
7.12 WuXi AppTech
7.12.1 WuXi AppTech Details
7.12.2 WuXi AppTech Major Business
7.12.3 WuXi AppTech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.12.4 WuXi AppTech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 WuXi AppTech Recent Developments/Updates
7.12.6 WuXi AppTech Competitive Strengths & Weaknesses
7.13 Asymchem
7.13.1 Asymchem Details
7.13.2 Asymchem Major Business
7.13.3 Asymchem Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.13.4 Asymchem Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Asymchem Recent Developments/Updates
7.13.6 Asymchem Competitive Strengths & Weaknesses
7.14 Porton
7.14.1 Porton Details
7.14.2 Porton Major Business
7.14.3 Porton Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.14.4 Porton Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Porton Recent Developments/Updates
7.14.6 Porton Competitive Strengths & Weaknesses
7.15 Amatsigroup
7.15.1 Amatsigroup Details
7.15.2 Amatsigroup Major Business
7.15.3 Amatsigroup Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.15.4 Amatsigroup Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Amatsigroup Recent Developments/Updates
7.15.6 Amatsigroup Competitive Strengths & Weaknesses
7.16 AcuraBio
7.16.1 AcuraBio Details
7.16.2 AcuraBio Major Business
7.16.3 AcuraBio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.16.4 AcuraBio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 AcuraBio Recent Developments/Updates
7.16.6 AcuraBio Competitive Strengths & Weaknesses
7.17 Moravek
7.17.1 Moravek Details
7.17.2 Moravek Major Business
7.17.3 Moravek Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.17.4 Moravek Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Moravek Recent Developments/Updates
7.17.6 Moravek Competitive Strengths & Weaknesses
7.18 Ascendia Pharmaceuticals
7.18.1 Ascendia Pharmaceuticals Details
7.18.2 Ascendia Pharmaceuticals Major Business
7.18.3 Ascendia Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.18.4 Ascendia Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Ascendia Pharmaceuticals Recent Developments/Updates
7.18.6 Ascendia Pharmaceuticals Competitive Strengths & Weaknesses
7.19 Ardena
7.19.1 Ardena Details
7.19.2 Ardena Major Business
7.19.3 Ardena Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.19.4 Ardena Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Ardena Recent Developments/Updates
7.19.6 Ardena Competitive Strengths & Weaknesses
7.20 CPL
7.20.1 CPL Details
7.20.2 CPL Major Business
7.20.3 CPL Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.20.4 CPL Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 CPL Recent Developments/Updates
7.20.6 CPL Competitive Strengths & Weaknesses
7.21 Arranta Bio
7.21.1 Arranta Bio Details
7.21.2 Arranta Bio Major Business
7.21.3 Arranta Bio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.21.4 Arranta Bio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.21.5 Arranta Bio Recent Developments/Updates
7.21.6 Arranta Bio Competitive Strengths & Weaknesses
7.22 UPM Pharmaceuticals
7.22.1 UPM Pharmaceuticals Details
7.22.2 UPM Pharmaceuticals Major Business
7.22.3 UPM Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.22.4 UPM Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.22.5 UPM Pharmaceuticals Recent Developments/Updates
7.22.6 UPM Pharmaceuticals Competitive Strengths & Weaknesses
7.23 FUJIFILM Diosynth Biotechnologies
7.23.1 FUJIFILM Diosynth Biotechnologies Details
7.23.2 FUJIFILM Diosynth Biotechnologies Major Business
7.23.3 FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.23.4 FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.23.5 FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
7.23.6 FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
7.24 Groupe Parima
7.24.1 Groupe Parima Details
7.24.2 Groupe Parima Major Business
7.24.3 Groupe Parima Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.24.4 Groupe Parima Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.24.5 Groupe Parima Recent Developments/Updates
7.24.6 Groupe Parima Competitive Strengths & Weaknesses
7.25 TBD Pharmatech
7.25.1 TBD Pharmatech Details
7.25.2 TBD Pharmatech Major Business
7.25.3 TBD Pharmatech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.25.4 TBD Pharmatech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.25.5 TBD Pharmatech Recent Developments/Updates
7.25.6 TBD Pharmatech Competitive Strengths & Weaknesses
7.26 Avid Bioservices
7.26.1 Avid Bioservices Details
7.26.2 Avid Bioservices Major Business
7.26.3 Avid Bioservices Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.26.4 Avid Bioservices Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.26.5 Avid Bioservices Recent Developments/Updates
7.26.6 Avid Bioservices Competitive Strengths & Weaknesses
7.27 Vetter Pharma
7.27.1 Vetter Pharma Details
7.27.2 Vetter Pharma Major Business
7.27.3 Vetter Pharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.27.4 Vetter Pharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.27.5 Vetter Pharma Recent Developments/Updates
7.27.6 Vetter Pharma Competitive Strengths & Weaknesses
7.28 NextPharma
7.28.1 NextPharma Details
7.28.2 NextPharma Major Business
7.28.3 NextPharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.28.4 NextPharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.28.5 NextPharma Recent Developments/Updates
7.28.6 NextPharma Competitive Strengths & Weaknesses
7.29 Alcami
7.29.1 Alcami Details
7.29.2 Alcami Major Business
7.29.3 Alcami Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.29.4 Alcami Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.29.5 Alcami Recent Developments/Updates
7.29.6 Alcami Competitive Strengths & Weaknesses
7.30 NerPharMa
7.30.1 NerPharMa Details
7.30.2 NerPharMa Major Business
7.30.3 NerPharMa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.30.4 NerPharMa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.30.5 NerPharMa Recent Developments/Updates
7.30.6 NerPharMa Competitive Strengths & Weaknesses
7.31 Vetio
7.31.1 Vetio Details
7.31.2 Vetio Major Business
7.31.3 Vetio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.31.4 Vetio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.31.5 Vetio Recent Developments/Updates
7.31.6 Vetio Competitive Strengths & Weaknesses
7.32 Societal CDMO
7.32.1 Societal CDMO Details
7.32.2 Societal CDMO Major Business
7.32.3 Societal CDMO Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.32.4 Societal CDMO Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.32.5 Societal CDMO Recent Developments/Updates
7.32.6 Societal CDMO Competitive Strengths & Weaknesses
7.33 ten23 health
7.33.1 ten23 health Details
7.33.2 ten23 health Major Business
7.33.3 ten23 health Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.33.4 ten23 health Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.33.5 ten23 health Recent Developments/Updates
7.33.6 ten23 health Competitive Strengths & Weaknesses
7.34 Piramal Pharma Solutions
7.34.1 Piramal Pharma Solutions Details
7.34.2 Piramal Pharma Solutions Major Business
7.34.3 Piramal Pharma Solutions Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.34.4 Piramal Pharma Solutions Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.34.5 Piramal Pharma Solutions Recent Developments/Updates
7.34.6 Piramal Pharma Solutions Competitive Strengths & Weaknesses
7.35 MedPharm
7.35.1 MedPharm Details
7.35.2 MedPharm Major Business
7.35.3 MedPharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.35.4 MedPharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.35.5 MedPharm Recent Developments/Updates
7.35.6 MedPharm Competitive Strengths & Weaknesses
7.36 Lundbeck
7.36.1 Lundbeck Details
7.36.2 Lundbeck Major Business
7.36.3 Lundbeck Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.36.4 Lundbeck Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.36.5 Lundbeck Recent Developments/Updates
7.36.6 Lundbeck Competitive Strengths & Weaknesses
7.37 AGC Pharma Chemicals
7.37.1 AGC Pharma Chemicals Details
7.37.2 AGC Pharma Chemicals Major Business
7.37.3 AGC Pharma Chemicals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.37.4 AGC Pharma Chemicals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.37.5 AGC Pharma Chemicals Recent Developments/Updates
7.37.6 AGC Pharma Chemicals Competitive Strengths & Weaknesses
7.38 BioVectra
7.38.1 BioVectra Details
7.38.2 BioVectra Major Business
7.38.3 BioVectra Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.38.4 BioVectra Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.38.5 BioVectra Recent Developments/Updates
7.38.6 BioVectra Competitive Strengths & Weaknesses
7.39 Pfizer CentreOne
7.39.1 Pfizer CentreOne Details
7.39.2 Pfizer CentreOne Major Business
7.39.3 Pfizer CentreOne Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.39.4 Pfizer CentreOne Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.39.5 Pfizer CentreOne Recent Developments/Updates
7.39.6 Pfizer CentreOne Competitive Strengths & Weaknesses
7.40 Jubilant Biosys
7.40.1 Jubilant Biosys Details
7.40.2 Jubilant Biosys Major Business
7.40.3 Jubilant Biosys Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.40.4 Jubilant Biosys Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) R
1.1 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction
1.2 World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Total Market by Region (by Headquarter Location)
1.3.1 World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size (2018-2029)
1.3.3 China Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size (2018-2029)
1.3.4 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size (2018-2029)
1.3.5 Japan Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size (2018-2029)
1.3.6 South Korea Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size (2018-2029)
1.3.7 ASEAN Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size (2018-2029)
1.3.8 India Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value (2018-2029)
2.2 World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Region
2.2.1 World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Region (2018-2023)
2.2.2 World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value Forecast by Region (2024-2029)
2.3 United States Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value (2018-2029)
2.4 China Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value (2018-2029)
2.5 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value (2018-2029)
2.6 Japan Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value (2018-2029)
2.7 South Korea Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value (2018-2029)
2.8 ASEAN Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value (2018-2029)
2.9 India Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value (2018-2029)
3 WORLD PHARMACEUTICAL CDMO (PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION) COMPANIES COMPETITIVE ANALYSIS
3.1 World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) in 2022
3.2.3 Global Concentration Ratios (CR8) for Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) in 2022
3.3 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Company Evaluation Quadrant
3.4 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market: Overall Company Footprint Analysis
3.4.1 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market: Region Footprint
3.4.2 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market: Company Product Type Footprint
3.4.3 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value Comparison
4.2.1 United States VS China: Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Companies and Market Share, 2018-2023
4.3.1 United States Based Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, (2018-2023)
4.4 China Based Companies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue and Market Share, 2018-2023
4.4.1 China Based Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, (2018-2023)
4.5 Rest of World Based Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Intermediate CDMO
5.2.2 API CDMO
5.2.3 Formulation CDMO
5.2.4 Protein CDMO
5.2.5 Gene Therapy CDMO
5.2.6 Cell Therapy CDMO
5.3 Market Segment by Type
5.3.1 World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type (2018-2023)
5.3.2 World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type (2024-2029)
5.3.3 World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical Company
6.2.2 Biotechnology Company
6.2.3 Generic Company
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application (2018-2023)
6.3.2 World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application (2024-2029)
6.3.3 World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Lonza
7.1.1 Lonza Details
7.1.2 Lonza Major Business
7.1.3 Lonza Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.1.4 Lonza Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Lonza Recent Developments/Updates
7.1.6 Lonza Competitive Strengths & Weaknesses
7.2 Catalent
7.2.1 Catalent Details
7.2.2 Catalent Major Business
7.2.3 Catalent Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.2.4 Catalent Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Catalent Recent Developments/Updates
7.2.6 Catalent Competitive Strengths & Weaknesses
7.3 Patheon (Thermo Fisher Scientific)
7.3.1 Patheon (Thermo Fisher Scientific) Details
7.3.2 Patheon (Thermo Fisher Scientific) Major Business
7.3.3 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.3.4 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Patheon (Thermo Fisher Scientific) Recent Developments/Updates
7.3.6 Patheon (Thermo Fisher Scientific) Competitive Strengths & Weaknesses
7.4 Aenova
7.4.1 Aenova Details
7.4.2 Aenova Major Business
7.4.3 Aenova Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.4.4 Aenova Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Aenova Recent Developments/Updates
7.4.6 Aenova Competitive Strengths & Weaknesses
7.5 Siegfried
7.5.1 Siegfried Details
7.5.2 Siegfried Major Business
7.5.3 Siegfried Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.5.4 Siegfried Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Siegfried Recent Developments/Updates
7.5.6 Siegfried Competitive Strengths & Weaknesses
7.6 Recipharm
7.6.1 Recipharm Details
7.6.2 Recipharm Major Business
7.6.3 Recipharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.6.4 Recipharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Recipharm Recent Developments/Updates
7.6.6 Recipharm Competitive Strengths & Weaknesses
7.7 Strides Shasun
7.7.1 Strides Shasun Details
7.7.2 Strides Shasun Major Business
7.7.3 Strides Shasun Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.7.4 Strides Shasun Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Strides Shasun Recent Developments/Updates
7.7.6 Strides Shasun Competitive Strengths & Weaknesses
7.8 Piramal
7.8.1 Piramal Details
7.8.2 Piramal Major Business
7.8.3 Piramal Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.8.4 Piramal Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Piramal Recent Developments/Updates
7.8.6 Piramal Competitive Strengths & Weaknesses
7.9 Metrics
7.9.1 Metrics Details
7.9.2 Metrics Major Business
7.9.3 Metrics Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.9.4 Metrics Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Metrics Recent Developments/Updates
7.9.6 Metrics Competitive Strengths & Weaknesses
7.10 AMRI
7.10.1 AMRI Details
7.10.2 AMRI Major Business
7.10.3 AMRI Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.10.4 AMRI Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 AMRI Recent Developments/Updates
7.10.6 AMRI Competitive Strengths & Weaknesses
7.11 Famar
7.11.1 Famar Details
7.11.2 Famar Major Business
7.11.3 Famar Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.11.4 Famar Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Famar Recent Developments/Updates
7.11.6 Famar Competitive Strengths & Weaknesses
7.12 WuXi AppTech
7.12.1 WuXi AppTech Details
7.12.2 WuXi AppTech Major Business
7.12.3 WuXi AppTech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.12.4 WuXi AppTech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 WuXi AppTech Recent Developments/Updates
7.12.6 WuXi AppTech Competitive Strengths & Weaknesses
7.13 Asymchem
7.13.1 Asymchem Details
7.13.2 Asymchem Major Business
7.13.3 Asymchem Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.13.4 Asymchem Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Asymchem Recent Developments/Updates
7.13.6 Asymchem Competitive Strengths & Weaknesses
7.14 Porton
7.14.1 Porton Details
7.14.2 Porton Major Business
7.14.3 Porton Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.14.4 Porton Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Porton Recent Developments/Updates
7.14.6 Porton Competitive Strengths & Weaknesses
7.15 Amatsigroup
7.15.1 Amatsigroup Details
7.15.2 Amatsigroup Major Business
7.15.3 Amatsigroup Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.15.4 Amatsigroup Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Amatsigroup Recent Developments/Updates
7.15.6 Amatsigroup Competitive Strengths & Weaknesses
7.16 AcuraBio
7.16.1 AcuraBio Details
7.16.2 AcuraBio Major Business
7.16.3 AcuraBio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.16.4 AcuraBio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 AcuraBio Recent Developments/Updates
7.16.6 AcuraBio Competitive Strengths & Weaknesses
7.17 Moravek
7.17.1 Moravek Details
7.17.2 Moravek Major Business
7.17.3 Moravek Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.17.4 Moravek Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Moravek Recent Developments/Updates
7.17.6 Moravek Competitive Strengths & Weaknesses
7.18 Ascendia Pharmaceuticals
7.18.1 Ascendia Pharmaceuticals Details
7.18.2 Ascendia Pharmaceuticals Major Business
7.18.3 Ascendia Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.18.4 Ascendia Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Ascendia Pharmaceuticals Recent Developments/Updates
7.18.6 Ascendia Pharmaceuticals Competitive Strengths & Weaknesses
7.19 Ardena
7.19.1 Ardena Details
7.19.2 Ardena Major Business
7.19.3 Ardena Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.19.4 Ardena Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Ardena Recent Developments/Updates
7.19.6 Ardena Competitive Strengths & Weaknesses
7.20 CPL
7.20.1 CPL Details
7.20.2 CPL Major Business
7.20.3 CPL Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.20.4 CPL Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 CPL Recent Developments/Updates
7.20.6 CPL Competitive Strengths & Weaknesses
7.21 Arranta Bio
7.21.1 Arranta Bio Details
7.21.2 Arranta Bio Major Business
7.21.3 Arranta Bio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.21.4 Arranta Bio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.21.5 Arranta Bio Recent Developments/Updates
7.21.6 Arranta Bio Competitive Strengths & Weaknesses
7.22 UPM Pharmaceuticals
7.22.1 UPM Pharmaceuticals Details
7.22.2 UPM Pharmaceuticals Major Business
7.22.3 UPM Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.22.4 UPM Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.22.5 UPM Pharmaceuticals Recent Developments/Updates
7.22.6 UPM Pharmaceuticals Competitive Strengths & Weaknesses
7.23 FUJIFILM Diosynth Biotechnologies
7.23.1 FUJIFILM Diosynth Biotechnologies Details
7.23.2 FUJIFILM Diosynth Biotechnologies Major Business
7.23.3 FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.23.4 FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.23.5 FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
7.23.6 FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
7.24 Groupe Parima
7.24.1 Groupe Parima Details
7.24.2 Groupe Parima Major Business
7.24.3 Groupe Parima Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.24.4 Groupe Parima Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.24.5 Groupe Parima Recent Developments/Updates
7.24.6 Groupe Parima Competitive Strengths & Weaknesses
7.25 TBD Pharmatech
7.25.1 TBD Pharmatech Details
7.25.2 TBD Pharmatech Major Business
7.25.3 TBD Pharmatech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.25.4 TBD Pharmatech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.25.5 TBD Pharmatech Recent Developments/Updates
7.25.6 TBD Pharmatech Competitive Strengths & Weaknesses
7.26 Avid Bioservices
7.26.1 Avid Bioservices Details
7.26.2 Avid Bioservices Major Business
7.26.3 Avid Bioservices Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.26.4 Avid Bioservices Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.26.5 Avid Bioservices Recent Developments/Updates
7.26.6 Avid Bioservices Competitive Strengths & Weaknesses
7.27 Vetter Pharma
7.27.1 Vetter Pharma Details
7.27.2 Vetter Pharma Major Business
7.27.3 Vetter Pharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.27.4 Vetter Pharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.27.5 Vetter Pharma Recent Developments/Updates
7.27.6 Vetter Pharma Competitive Strengths & Weaknesses
7.28 NextPharma
7.28.1 NextPharma Details
7.28.2 NextPharma Major Business
7.28.3 NextPharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.28.4 NextPharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.28.5 NextPharma Recent Developments/Updates
7.28.6 NextPharma Competitive Strengths & Weaknesses
7.29 Alcami
7.29.1 Alcami Details
7.29.2 Alcami Major Business
7.29.3 Alcami Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.29.4 Alcami Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.29.5 Alcami Recent Developments/Updates
7.29.6 Alcami Competitive Strengths & Weaknesses
7.30 NerPharMa
7.30.1 NerPharMa Details
7.30.2 NerPharMa Major Business
7.30.3 NerPharMa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.30.4 NerPharMa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.30.5 NerPharMa Recent Developments/Updates
7.30.6 NerPharMa Competitive Strengths & Weaknesses
7.31 Vetio
7.31.1 Vetio Details
7.31.2 Vetio Major Business
7.31.3 Vetio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.31.4 Vetio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.31.5 Vetio Recent Developments/Updates
7.31.6 Vetio Competitive Strengths & Weaknesses
7.32 Societal CDMO
7.32.1 Societal CDMO Details
7.32.2 Societal CDMO Major Business
7.32.3 Societal CDMO Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.32.4 Societal CDMO Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.32.5 Societal CDMO Recent Developments/Updates
7.32.6 Societal CDMO Competitive Strengths & Weaknesses
7.33 ten23 health
7.33.1 ten23 health Details
7.33.2 ten23 health Major Business
7.33.3 ten23 health Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.33.4 ten23 health Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.33.5 ten23 health Recent Developments/Updates
7.33.6 ten23 health Competitive Strengths & Weaknesses
7.34 Piramal Pharma Solutions
7.34.1 Piramal Pharma Solutions Details
7.34.2 Piramal Pharma Solutions Major Business
7.34.3 Piramal Pharma Solutions Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.34.4 Piramal Pharma Solutions Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.34.5 Piramal Pharma Solutions Recent Developments/Updates
7.34.6 Piramal Pharma Solutions Competitive Strengths & Weaknesses
7.35 MedPharm
7.35.1 MedPharm Details
7.35.2 MedPharm Major Business
7.35.3 MedPharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.35.4 MedPharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.35.5 MedPharm Recent Developments/Updates
7.35.6 MedPharm Competitive Strengths & Weaknesses
7.36 Lundbeck
7.36.1 Lundbeck Details
7.36.2 Lundbeck Major Business
7.36.3 Lundbeck Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.36.4 Lundbeck Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.36.5 Lundbeck Recent Developments/Updates
7.36.6 Lundbeck Competitive Strengths & Weaknesses
7.37 AGC Pharma Chemicals
7.37.1 AGC Pharma Chemicals Details
7.37.2 AGC Pharma Chemicals Major Business
7.37.3 AGC Pharma Chemicals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.37.4 AGC Pharma Chemicals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.37.5 AGC Pharma Chemicals Recent Developments/Updates
7.37.6 AGC Pharma Chemicals Competitive Strengths & Weaknesses
7.38 BioVectra
7.38.1 BioVectra Details
7.38.2 BioVectra Major Business
7.38.3 BioVectra Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.38.4 BioVectra Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.38.5 BioVectra Recent Developments/Updates
7.38.6 BioVectra Competitive Strengths & Weaknesses
7.39 Pfizer CentreOne
7.39.1 Pfizer CentreOne Details
7.39.2 Pfizer CentreOne Major Business
7.39.3 Pfizer CentreOne Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.39.4 Pfizer CentreOne Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
7.39.5 Pfizer CentreOne Recent Developments/Updates
7.39.6 Pfizer CentreOne Competitive Strengths & Weaknesses
7.40 Jubilant Biosys
7.40.1 Jubilant Biosys Details
7.40.2 Jubilant Biosys Major Business
7.40.3 Jubilant Biosys Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
7.40.4 Jubilant Biosys Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) R
LIST OF TABLES
Table 1. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Players in 2022
Table 12. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Company Evaluation Quadrant
Table 14. Head Office of Key Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Player
Table 15. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market: Company Product Type Footprint
Table 16. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market: Company Product Application Footprint
Table 17. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Mergers & Acquisitions Activity
Table 18. United States VS China Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Companies, Headquarters (States, Country)
Table 21. United States Based Companies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share (2018-2023)
Table 23. China Based Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Companies, Headquarters (Province, Country)
Table 24. China Based Companies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share (2018-2023)
Table 26. Rest of World Based Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share (2018-2023)
Table 29. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type (2018-2023) & (USD Million)
Table 31. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type (2024-2029) & (USD Million)
Table 32. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application (2018-2023) & (USD Million)
Table 34. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application (2024-2029) & (USD Million)
Table 35. Lonza Basic Information, Area Served and Competitors
Table 36. Lonza Major Business
Table 37. Lonza Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 38. Lonza Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Lonza Recent Developments/Updates
Table 40. Lonza Competitive Strengths & Weaknesses
Table 41. Catalent Basic Information, Area Served and Competitors
Table 42. Catalent Major Business
Table 43. Catalent Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 44. Catalent Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Catalent Recent Developments/Updates
Table 46. Catalent Competitive Strengths & Weaknesses
Table 47. Patheon (Thermo Fisher Scientific) Basic Information, Area Served and Competitors
Table 48. Patheon (Thermo Fisher Scientific) Major Business
Table 49. Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 50. Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Patheon (Thermo Fisher Scientific) Recent Developments/Updates
Table 52. Patheon (Thermo Fisher Scientific) Competitive Strengths & Weaknesses
Table 53. Aenova Basic Information, Area Served and Competitors
Table 54. Aenova Major Business
Table 55. Aenova Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 56. Aenova Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Aenova Recent Developments/Updates
Table 58. Aenova Competitive Strengths & Weaknesses
Table 59. Siegfried Basic Information, Area Served and Competitors
Table 60. Siegfried Major Business
Table 61. Siegfried Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 62. Siegfried Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Siegfried Recent Developments/Updates
Table 64. Siegfried Competitive Strengths & Weaknesses
Table 65. Recipharm Basic Information, Area Served and Competitors
Table 66. Recipharm Major Business
Table 67. Recipharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 68. Recipharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Recipharm Recent Developments/Updates
Table 70. Recipharm Competitive Strengths & Weaknesses
Table 71. Strides Shasun Basic Information, Area Served and Competitors
Table 72. Strides Shasun Major Business
Table 73. Strides Shasun Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 74. Strides Shasun Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Strides Shasun Recent Developments/Updates
Table 76. Strides Shasun Competitive Strengths & Weaknesses
Table 77. Piramal Basic Information, Area Served and Competitors
Table 78. Piramal Major Business
Table 79. Piramal Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 80. Piramal Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Piramal Recent Developments/Updates
Table 82. Piramal Competitive Strengths & Weaknesses
Table 83. Metrics Basic Information, Area Served and Competitors
Table 84. Metrics Major Business
Table 85. Metrics Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 86. Metrics Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Metrics Recent Developments/Updates
Table 88. Metrics Competitive Strengths & Weaknesses
Table 89. AMRI Basic Information, Area Served and Competitors
Table 90. AMRI Major Business
Table 91. AMRI Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 92. AMRI Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. AMRI Recent Developments/Updates
Table 94. AMRI Competitive Strengths & Weaknesses
Table 95. Famar Basic Information, Area Served and Competitors
Table 96. Famar Major Business
Table 97. Famar Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 98. Famar Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Famar Recent Developments/Updates
Table 100. Famar Competitive Strengths & Weaknesses
Table 101. WuXi AppTech Basic Information, Area Served and Competitors
Table 102. WuXi AppTech Major Business
Table 103. WuXi AppTech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 104. WuXi AppTech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. WuXi AppTech Recent Developments/Updates
Table 106. WuXi AppTech Competitive Strengths & Weaknesses
Table 107. Asymchem Basic Information, Area Served and Competitors
Table 108. Asymchem Major Business
Table 109. Asymchem Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 110. Asymchem Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Asymchem Recent Developments/Updates
Table 112. Asymchem Competitive Strengths & Weaknesses
Table 113. Porton Basic Information, Area Served and Competitors
Table 114. Porton Major Business
Table 115. Porton Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 116. Porton Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Porton Recent Developments/Updates
Table 118. Porton Competitive Strengths & Weaknesses
Table 119. Amatsigroup Basic Information, Area Served and Competitors
Table 120. Amatsigroup Major Business
Table 121. Amatsigroup Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 122. Amatsigroup Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Amatsigroup Recent Developments/Updates
Table 124. Amatsigroup Competitive Strengths & Weaknesses
Table 125. AcuraBio Basic Information, Area Served and Competitors
Table 126. AcuraBio Major Business
Table 127. AcuraBio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 128. AcuraBio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. AcuraBio Recent Developments/Updates
Table 130. AcuraBio Competitive Strengths & Weaknesses
Table 131. Moravek Basic Information, Area Served and Competitors
Table 132. Moravek Major Business
Table 133. Moravek Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 134. Moravek Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Moravek Recent Developments/Updates
Table 136. Moravek Competitive Strengths & Weaknesses
Table 137. Ascendia Pharmaceuticals Basic Information, Area Served and Competitors
Table 138. Ascendia Pharmaceuticals Major Business
Table 139. Ascendia Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 140. Ascendia Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Ascendia Pharmaceuticals Recent Developments/Updates
Table 142. Ascendia Pharmaceuticals Competitive Strengths & Weaknesses
Table 143. Ardena Basic Information, Area Served and Competitors
Table 144. Ardena Major Business
Table 145. Ardena Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 146. Ardena Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Ardena Recent Developments/Updates
Table 148. Ardena Competitive Strengths & Weaknesses
Table 149. CPL Basic Information, Area Served and Competitors
Table 150. CPL Major Business
Table 151. CPL Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 152. CPL Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 153. CPL Recent Developments/Updates
Table 154. CPL Competitive Strengths & Weaknesses
Table 155. Arranta Bio Basic Information, Area Served and Competitors
Table 156. Arranta Bio Major Business
Table 157. Arranta Bio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 158. Arranta Bio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 159. Arranta Bio Recent Developments/Updates
Table 160. Arranta Bio Competitive Strengths & Weaknesses
Table 161. UPM Pharmaceuticals Basic Information, Area Served and Competitors
Table 162. UPM Pharmaceuticals Major Business
Table 163. UPM Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 164. UPM Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 165. UPM Pharmaceuticals Recent Developments/Updates
Table 166. UPM Pharmaceuticals Competitive Strengths & Weaknesses
Table 167. FUJIFILM Diosynth Biotechnologies Basic Information, Area Served and Competitors
Table 168. FUJIFILM Diosynth Biotechnologies Major Business
Table 169. FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 170. FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 171. FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
Table 172. FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
Table 173. Groupe Parima Basic Information, Area Served and Competitors
Table 174. Groupe Parima Major Business
Table 175. Groupe Parima Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 176. Groupe Parima Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 177. Groupe Parima Recent Developments/Updates
Table 178. Groupe Parima Competitive Strengths & Weaknesses
Table 179. TBD Pharmatech Basic Information, Area Served and Competitors
Table 180. TBD Pharmatech Major Business
Table 181. TBD Pharmatech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 182. TBD Pharmatech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 183. TBD Pharmatech Recent Developments/Updates
Table 184. TBD Pharmatech Competitive Strengths & Weaknesses
Table 185. Avid Bioservices Basic Information, Area Served and Competitors
Table 186. Avid Bioservices Major Business
Table 187. Avid Bioservices Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 188. Avid Bioservices Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 189. Avid Bioservices Recent Developments/Updates
Table 190. Avid Bioservices Competitive Strengths & Weaknesses
Table 191. Vetter Pharma Basic Information, Area Served and Competitors
Table 192. Vetter Pharma Major Business
Table 193. Vetter Pharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 194. Vetter Pharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 195. Vetter Pharma Recent Developments/Updates
Table 196. Vetter Pharma Competitive Strengths & Weaknesses
Table 197. NextPharma Basic Information, Area Served and Competitors
Table 198. NextPharma Major Business
Table 199. NextPharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 200. NextPharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 201. NextPharma Recent Developments/Updates
Table 202. NextPharma Competitive Strengths & Weaknesses
Table 203. Alcami Basic Information, Area Served and Competitors
Table 204. AlcamiMajor Business
Table 205. Alcami Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 206. Alcami Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 207. Alcami Recent Developments/Updates
Table 208. Alcami Competitive Strengths & Weaknesses
Table 209. NerPharMa Basic Information, Area Served and Competitors
Table 210. NerPharMa Major Business
Table 211. NerPharMa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 212. NerPharMa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 213. NerPharMa Recent Developments/Updates
Table 214. NerPharMa Competitive Strengths & Weaknesses
Table 215. Vetio Basic Information, Area Served and Competitors
Table 216. Vetio Major Business
Table 217. Vetio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 218. Vetio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 219. Vetio Recent Developments/Updates
Table 220. Vetio Competitive Strengths & Weaknesses
Table 221. Societal CDMO Basic Information, Area Served and Competitors
Table 222. Societal CDMO Major Business
Table 223. Societal CDMO Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 224. Societal CDMO Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 225. Societal CDMO Recent Developments/Updates
Table 226. Societal CDMO Competitive Strengths & Weaknesses
Table 227. ten23 health Basic Information, Area Served and Competitors
Table 228. ten23 health Major Business
Table 229. ten23 health Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 230. ten23 health Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 231. ten23 health Recent Developments/Updates
Table 232. ten23 health Competitive Strengths & Weaknesses
Table 233. Piramal Pharma Solutions Basic Information, Area Served and Competitors
Table 234. Piramal Pharma Solutions Major Business
Table 235. Piramal Pharma Solutions Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 236. Piramal Pharma Solutions Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 237. Piramal Pharma Solutions Recent Developments/Updates
Table 238. Piramal Pharma Solutions Competitive Strengths & Weaknesses
Table 239. MedPharm Basic Information, Area Served and Competitors
Table 240. MedPharm Major Business
Table 241. MedPharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 242. MedPharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 243. MedPharm Recent Developments/Updates
Table 244. MedPharm Competitive Strengths & Weaknesses
Table 245. Lundbeck Basic Information, Area Served and Competitors
Table 246. Lundbeck Major Business
Table 247. Lundbeck Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 248. Lundbeck Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 249. Lundbeck Recent Developments/Updates
Table 250. Lundbeck Competitive Strengths & Weaknesses
Table 251. AGC Pharma Chemicals Basic Information, Area Served and Competitors
Table 252. AGC Pharma Chemicals Major Business
Table 253. AGC Pharma Chemicals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 254. AGC Pharma Chemicals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 255. AGC Pharma Chemicals Recent Developments/Updates
Table 256. AGC Pharma Chemicals Competitive Strengths & Weaknesses
Table 257. BioVectra Basic Information, Area Served and Competitors
Table 258. BioVectra Major Business
Table 259. BioVectra Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 260. BioVectra Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 261. BioVectra Recent Developments/Updates
Table 262. BioVectra Competitive Strengths & Weaknesses
Table 263. Pfizer CentreOne Basic Information, Area Served and Competitors
Table 264. Pfizer CentreOne Major Business
Table 265. Pfizer CentreOne Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 266. Pfizer CentreOne Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 267. Pfizer CentreOne Recent Developments/Updates
Table 268. Pfizer CentreOne Competitive Strengths & Weaknesses
Table 269. Jubilant Biosys Basic Information, Area Served and Competitors
Table 270. Jubilant Biosys Major Business
Table 271. Jubilant Biosys Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 272. Jubilant Biosys Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 273. Jubilant Biosys Recent Developments/Updates
Table 274. Jubilant Biosys Competitive Strengths & Weaknesses
Table 275. Global Key Players of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Upstream (Raw Materials)
Table 276. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Typical Customers
Table 1. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Players in 2022
Table 12. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Company Evaluation Quadrant
Table 14. Head Office of Key Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Player
Table 15. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market: Company Product Type Footprint
Table 16. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market: Company Product Application Footprint
Table 17. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Mergers & Acquisitions Activity
Table 18. United States VS China Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Companies, Headquarters (States, Country)
Table 21. United States Based Companies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share (2018-2023)
Table 23. China Based Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Companies, Headquarters (Province, Country)
Table 24. China Based Companies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share (2018-2023)
Table 26. Rest of World Based Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share (2018-2023)
Table 29. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type (2018-2023) & (USD Million)
Table 31. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type (2024-2029) & (USD Million)
Table 32. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application (2018-2023) & (USD Million)
Table 34. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application (2024-2029) & (USD Million)
Table 35. Lonza Basic Information, Area Served and Competitors
Table 36. Lonza Major Business
Table 37. Lonza Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 38. Lonza Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Lonza Recent Developments/Updates
Table 40. Lonza Competitive Strengths & Weaknesses
Table 41. Catalent Basic Information, Area Served and Competitors
Table 42. Catalent Major Business
Table 43. Catalent Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 44. Catalent Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Catalent Recent Developments/Updates
Table 46. Catalent Competitive Strengths & Weaknesses
Table 47. Patheon (Thermo Fisher Scientific) Basic Information, Area Served and Competitors
Table 48. Patheon (Thermo Fisher Scientific) Major Business
Table 49. Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 50. Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Patheon (Thermo Fisher Scientific) Recent Developments/Updates
Table 52. Patheon (Thermo Fisher Scientific) Competitive Strengths & Weaknesses
Table 53. Aenova Basic Information, Area Served and Competitors
Table 54. Aenova Major Business
Table 55. Aenova Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 56. Aenova Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Aenova Recent Developments/Updates
Table 58. Aenova Competitive Strengths & Weaknesses
Table 59. Siegfried Basic Information, Area Served and Competitors
Table 60. Siegfried Major Business
Table 61. Siegfried Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 62. Siegfried Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Siegfried Recent Developments/Updates
Table 64. Siegfried Competitive Strengths & Weaknesses
Table 65. Recipharm Basic Information, Area Served and Competitors
Table 66. Recipharm Major Business
Table 67. Recipharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 68. Recipharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Recipharm Recent Developments/Updates
Table 70. Recipharm Competitive Strengths & Weaknesses
Table 71. Strides Shasun Basic Information, Area Served and Competitors
Table 72. Strides Shasun Major Business
Table 73. Strides Shasun Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 74. Strides Shasun Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Strides Shasun Recent Developments/Updates
Table 76. Strides Shasun Competitive Strengths & Weaknesses
Table 77. Piramal Basic Information, Area Served and Competitors
Table 78. Piramal Major Business
Table 79. Piramal Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 80. Piramal Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Piramal Recent Developments/Updates
Table 82. Piramal Competitive Strengths & Weaknesses
Table 83. Metrics Basic Information, Area Served and Competitors
Table 84. Metrics Major Business
Table 85. Metrics Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 86. Metrics Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Metrics Recent Developments/Updates
Table 88. Metrics Competitive Strengths & Weaknesses
Table 89. AMRI Basic Information, Area Served and Competitors
Table 90. AMRI Major Business
Table 91. AMRI Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 92. AMRI Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. AMRI Recent Developments/Updates
Table 94. AMRI Competitive Strengths & Weaknesses
Table 95. Famar Basic Information, Area Served and Competitors
Table 96. Famar Major Business
Table 97. Famar Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 98. Famar Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Famar Recent Developments/Updates
Table 100. Famar Competitive Strengths & Weaknesses
Table 101. WuXi AppTech Basic Information, Area Served and Competitors
Table 102. WuXi AppTech Major Business
Table 103. WuXi AppTech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 104. WuXi AppTech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. WuXi AppTech Recent Developments/Updates
Table 106. WuXi AppTech Competitive Strengths & Weaknesses
Table 107. Asymchem Basic Information, Area Served and Competitors
Table 108. Asymchem Major Business
Table 109. Asymchem Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 110. Asymchem Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Asymchem Recent Developments/Updates
Table 112. Asymchem Competitive Strengths & Weaknesses
Table 113. Porton Basic Information, Area Served and Competitors
Table 114. Porton Major Business
Table 115. Porton Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 116. Porton Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Porton Recent Developments/Updates
Table 118. Porton Competitive Strengths & Weaknesses
Table 119. Amatsigroup Basic Information, Area Served and Competitors
Table 120. Amatsigroup Major Business
Table 121. Amatsigroup Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 122. Amatsigroup Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Amatsigroup Recent Developments/Updates
Table 124. Amatsigroup Competitive Strengths & Weaknesses
Table 125. AcuraBio Basic Information, Area Served and Competitors
Table 126. AcuraBio Major Business
Table 127. AcuraBio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 128. AcuraBio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. AcuraBio Recent Developments/Updates
Table 130. AcuraBio Competitive Strengths & Weaknesses
Table 131. Moravek Basic Information, Area Served and Competitors
Table 132. Moravek Major Business
Table 133. Moravek Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 134. Moravek Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Moravek Recent Developments/Updates
Table 136. Moravek Competitive Strengths & Weaknesses
Table 137. Ascendia Pharmaceuticals Basic Information, Area Served and Competitors
Table 138. Ascendia Pharmaceuticals Major Business
Table 139. Ascendia Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 140. Ascendia Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Ascendia Pharmaceuticals Recent Developments/Updates
Table 142. Ascendia Pharmaceuticals Competitive Strengths & Weaknesses
Table 143. Ardena Basic Information, Area Served and Competitors
Table 144. Ardena Major Business
Table 145. Ardena Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 146. Ardena Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Ardena Recent Developments/Updates
Table 148. Ardena Competitive Strengths & Weaknesses
Table 149. CPL Basic Information, Area Served and Competitors
Table 150. CPL Major Business
Table 151. CPL Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 152. CPL Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 153. CPL Recent Developments/Updates
Table 154. CPL Competitive Strengths & Weaknesses
Table 155. Arranta Bio Basic Information, Area Served and Competitors
Table 156. Arranta Bio Major Business
Table 157. Arranta Bio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 158. Arranta Bio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 159. Arranta Bio Recent Developments/Updates
Table 160. Arranta Bio Competitive Strengths & Weaknesses
Table 161. UPM Pharmaceuticals Basic Information, Area Served and Competitors
Table 162. UPM Pharmaceuticals Major Business
Table 163. UPM Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 164. UPM Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 165. UPM Pharmaceuticals Recent Developments/Updates
Table 166. UPM Pharmaceuticals Competitive Strengths & Weaknesses
Table 167. FUJIFILM Diosynth Biotechnologies Basic Information, Area Served and Competitors
Table 168. FUJIFILM Diosynth Biotechnologies Major Business
Table 169. FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 170. FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 171. FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
Table 172. FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
Table 173. Groupe Parima Basic Information, Area Served and Competitors
Table 174. Groupe Parima Major Business
Table 175. Groupe Parima Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 176. Groupe Parima Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 177. Groupe Parima Recent Developments/Updates
Table 178. Groupe Parima Competitive Strengths & Weaknesses
Table 179. TBD Pharmatech Basic Information, Area Served and Competitors
Table 180. TBD Pharmatech Major Business
Table 181. TBD Pharmatech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 182. TBD Pharmatech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 183. TBD Pharmatech Recent Developments/Updates
Table 184. TBD Pharmatech Competitive Strengths & Weaknesses
Table 185. Avid Bioservices Basic Information, Area Served and Competitors
Table 186. Avid Bioservices Major Business
Table 187. Avid Bioservices Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 188. Avid Bioservices Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 189. Avid Bioservices Recent Developments/Updates
Table 190. Avid Bioservices Competitive Strengths & Weaknesses
Table 191. Vetter Pharma Basic Information, Area Served and Competitors
Table 192. Vetter Pharma Major Business
Table 193. Vetter Pharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 194. Vetter Pharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 195. Vetter Pharma Recent Developments/Updates
Table 196. Vetter Pharma Competitive Strengths & Weaknesses
Table 197. NextPharma Basic Information, Area Served and Competitors
Table 198. NextPharma Major Business
Table 199. NextPharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 200. NextPharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 201. NextPharma Recent Developments/Updates
Table 202. NextPharma Competitive Strengths & Weaknesses
Table 203. Alcami Basic Information, Area Served and Competitors
Table 204. AlcamiMajor Business
Table 205. Alcami Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 206. Alcami Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 207. Alcami Recent Developments/Updates
Table 208. Alcami Competitive Strengths & Weaknesses
Table 209. NerPharMa Basic Information, Area Served and Competitors
Table 210. NerPharMa Major Business
Table 211. NerPharMa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 212. NerPharMa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 213. NerPharMa Recent Developments/Updates
Table 214. NerPharMa Competitive Strengths & Weaknesses
Table 215. Vetio Basic Information, Area Served and Competitors
Table 216. Vetio Major Business
Table 217. Vetio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 218. Vetio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 219. Vetio Recent Developments/Updates
Table 220. Vetio Competitive Strengths & Weaknesses
Table 221. Societal CDMO Basic Information, Area Served and Competitors
Table 222. Societal CDMO Major Business
Table 223. Societal CDMO Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 224. Societal CDMO Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 225. Societal CDMO Recent Developments/Updates
Table 226. Societal CDMO Competitive Strengths & Weaknesses
Table 227. ten23 health Basic Information, Area Served and Competitors
Table 228. ten23 health Major Business
Table 229. ten23 health Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 230. ten23 health Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 231. ten23 health Recent Developments/Updates
Table 232. ten23 health Competitive Strengths & Weaknesses
Table 233. Piramal Pharma Solutions Basic Information, Area Served and Competitors
Table 234. Piramal Pharma Solutions Major Business
Table 235. Piramal Pharma Solutions Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 236. Piramal Pharma Solutions Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 237. Piramal Pharma Solutions Recent Developments/Updates
Table 238. Piramal Pharma Solutions Competitive Strengths & Weaknesses
Table 239. MedPharm Basic Information, Area Served and Competitors
Table 240. MedPharm Major Business
Table 241. MedPharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 242. MedPharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 243. MedPharm Recent Developments/Updates
Table 244. MedPharm Competitive Strengths & Weaknesses
Table 245. Lundbeck Basic Information, Area Served and Competitors
Table 246. Lundbeck Major Business
Table 247. Lundbeck Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 248. Lundbeck Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 249. Lundbeck Recent Developments/Updates
Table 250. Lundbeck Competitive Strengths & Weaknesses
Table 251. AGC Pharma Chemicals Basic Information, Area Served and Competitors
Table 252. AGC Pharma Chemicals Major Business
Table 253. AGC Pharma Chemicals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 254. AGC Pharma Chemicals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 255. AGC Pharma Chemicals Recent Developments/Updates
Table 256. AGC Pharma Chemicals Competitive Strengths & Weaknesses
Table 257. BioVectra Basic Information, Area Served and Competitors
Table 258. BioVectra Major Business
Table 259. BioVectra Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 260. BioVectra Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 261. BioVectra Recent Developments/Updates
Table 262. BioVectra Competitive Strengths & Weaknesses
Table 263. Pfizer CentreOne Basic Information, Area Served and Competitors
Table 264. Pfizer CentreOne Major Business
Table 265. Pfizer CentreOne Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 266. Pfizer CentreOne Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 267. Pfizer CentreOne Recent Developments/Updates
Table 268. Pfizer CentreOne Competitive Strengths & Weaknesses
Table 269. Jubilant Biosys Basic Information, Area Served and Competitors
Table 270. Jubilant Biosys Major Business
Table 271. Jubilant Biosys Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Services
Table 272. Jubilant Biosys Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 273. Jubilant Biosys Recent Developments/Updates
Table 274. Jubilant Biosys Competitive Strengths & Weaknesses
Table 275. Global Key Players of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Upstream (Raw Materials)
Table 276. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Typical Customers
LIST OF FIGURES
Figure 1. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Picture
Figure 2. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Total Market Size (2018-2029) & (USD Million)
Figure 4. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (2018-2029) & (USD Million)
Figure 13. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value (2018-2029) & (USD Million)
Figure 16. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value (2018-2029) & (USD Million)
Figure 18. China Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Valu
Figure 1. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Picture
Figure 2. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Total Market Size (2018-2029) & (USD Million)
Figure 4. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (2018-2029) & (USD Million)
Figure 13. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value (2018-2029) & (USD Million)
Figure 16. World Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value (2018-2029) & (USD Million)
Figure 18. China Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Valu
